Summary
The aim of the study was to evaluate whether the combination of ketanserin with captopril exerts an additive antihypertensive effect, as compared with single drug treatment. Twelve patients with uncomplicated moderate essential hypertension received, according to a randomized, double-blind, crossover design, ketanserin (40 mg twice daily), captopril (50 mg twice daily), the combination of the two drugs at these dosages, and the corresponding placebo, each treatment being given for 1 month. Both ketanserin and captopril as monotherapy similarly and significantly reduced blood pressure as compared with placebo (p<0.001). The combination treatment of ketanserin plus captopril further and significantly reduced blood pressure when compared with single drug treatment (p<0.001). Moreover, the percentage of responders and patients whose blood pressure was normalized were significantly greater under the combined treatment than under ketanserin or captopril monotherpy (p<0.001). These data indicate that the combination of ketanserin plus captopril exerts a clear additive antihypertensive effect when compared with each treatment as monotherapy, a finding that suggests this combination can be usefully employed in the treatment of hpertensive patients.
Similar content being viewed by others
References
Vanhoutte PM, Amery A, Birkenhager W, Breckenridge A, Bühler F, et al. Serotonergic mechanisms in hypertension. Focus on the effects of ketanserin. Hypertension 1988;11:111–133.
Breckenridge A. Ketanserin — a new antihypertensive agent. J Hypertens 1986;4(Suppl 1):S13-S16.
Rosendorf C, Murray GD, for the International Study Group. Ketanserin versus metoprolol and hydrochlorothiazide in essential hypertension: Only ketanserin's hypertensive effect is age-related. J Hypertension 1986;4(Suppl 6):S109-S111.
Meyer P, Safa M, on behalf of a Multicentre Practice Trial Group. Comparison of ketanserin with captopril in older hypertensives: A double-blind randomized trial. Drugs 1988;36(Suppl 1):144–147.
Salvetti A. Angiotensin-converting enzyme inhibitors in the treatment of mild to moderate essential hypertension. Am J Hypertens 1989;2:945–995.
Symoens J, Janssens M. Ketanserin: A novel cardiovascular drug. Drug Devel Res 1986;8:159–172.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Lavezzaro, G., Ladetto, P.E., Valente, M. et al. Ketanserin and captopril interaction in the treatment of essential hypertensives. Cardiovasc Drug Ther 4, 119–122 (1990). https://doi.org/10.1007/BF00053442
Issue Date:
DOI: https://doi.org/10.1007/BF00053442